NCT05887609
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05887609
Title An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Colorado, Denver
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Colorado Hospital RECRUITING Aurora Colorado 80045 United States Details
Northwestern Memorial Hospital RECRUITING Chicago Illinois 60611 United States Details
University of Pennsylvania Health System, Perelman Center for Advanced Medicine RECRUITING Philadelphia Pennsylvania 19104 United States Details
UPMC Magee-Women's Hospital RECRUITING Pittsburgh Pennsylvania 15213 United States Details
University of Wisconsin - Carbone Cancer Center - University Hospital RECRUITING Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field